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Background: The lipid composition of plasma is known to vary due to both phenotypic factors such as age, gender
and BMI as well as with various diseases including cancer and neurological disorders. However, there is little
investigation into the variation in the lipidome due to exercise and/ or metabolic challenges. The objectives of this
present study were (i) To identify the glycerophospholipid, sphingolipids and ceramide changes in response to an oral
lipid tolerance test (OLTT) in healthy adults and (ii) To identify the effect of aerobic fitness level on lipidomic profiles.
Methods: 214 healthy adults aged 18–60 years were recruited as part of a metabolic challenge study. A sub-group of
40 volunteers were selected for lipidomic analysis based on their aerobic fitness level. Ceramides, glycerophospholipids
and sphingomyelins were quantified in baseline fasting plasma samples as well as at 60, 120, 180, 240 and 300 min
following a lipid challenge using high-throughput flow injection ESI-MS/MS.
Results: Mixed model repeated measures analysis identified lipids which were significantly changing over the time
course of the lipid challenge. Included in these lipids were lysophosphoethanolamines (LPE), phosphoethanolamines
(PE), phosphoglycerides (PG) and ceramides (Cer). Five lipids (LPE a C18:2, LPE a C18:1, PE aa C36:2, PE aa C36:3
and N-C16:1-Cer) had a fold change > 1.5 at 120 min following the challenge and these lipids remained elevated.
Furthermore, three of these lipids (LPE a C18:2, PE aa C36:2 and PE aa C36:3) were predictive of fasting and peak
plasma TAG concentrations following the OLTT. Further analysis revealed that fitness level has a significant impact
on the response to the OLTT: in particular significant differences between fitness groups were observed for
phosphatidylcholines (PC), sphingomyelins (SM) and ceramides.
Conclusion: This study identified specific lipids which were modulated by an acute lipid challenge. Furthermore,
it identified a series of lipids which were modulated by fitness level. Future lipidomic studies should take into
account environmental factors such as diet and fitness level during biomarker discovery work.
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Table 1 Demographics of study population
Mean ± SD
Age (years) 35 ± 14
Weight (Kg) 80.76 ± 19.76
BMI (kg/m2) 26.5 ± 6.3
Body fat (%) 27.7 ± 13.7
VO2MAX (ml/min/kg) 41.1 ± 16.2
Data are means ± SD
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Lipidomics characterises the composition of lipid molecu-
lar species in biological systems [1, 2]. Recent development
in lipidomics research has been largely driven by the
advancements in mass spectrometry (MS) and innovations
in chromatographic technologies. To date lipidomic
investigations have focused largely on the measurement of
alterations of lipids at systems-level indicative of disease,
environmental perturbations or response to diet, drugs
and toxins as well as genetics [3] and thus, lipidomics is
providing new opportunities to understand the function of
lipids in biological systems [4]. Recent studies have
demonstrated the application of lipidomics in studies
investigating diabetes, cystic fibrosis, respiratory diseases
and neurodegenerative diseases. These studies have clearly
indicated the potential usefulness of lipidomics both to
generate biomarkers of disease and to probe signalling and
metabolic processes [5–9].
Lipidomic approaches have started to gain momentum
in the area of nutrition and food research. Examples of
use can be broadly defined into two categories: (1) appli-
cation of lipidomics to further our understanding of the
effects of specific diets and foods on metabolic pathways
and (2) application to the study of diet related diseases
[10–12]. Significant knowledge has been obtained
through the application of lipidomics in obesity and type
2 diabetes research [13, 14]. Furthermore, lipidomic
patterns have been linked to dietary intake revealing the
potential use for identifying biomarkers of food intake
[15]. Recent applications of lipidomics has revealed a
new set of lipid signalling molecules that play a key role
in whole body metabolism and physiology offering new
targets for the treatment of type 2 diabetes and the
metabolic syndrome [16].
In the field of nutrition research the use of meal
challenges to characterise subjects and to identify subtle
changes following interventions is emerging as an
important tool in nutrition research [17–22]. Healthy
humans have the ability to maintain homeostasis
through a multitude of nutritionally regulated processes.
Therefore time-dependant changes in response to food
is of great importance and provides information about
the health of an individual. Biochemical alterations can
be examined using challenge tests such as a standard
meal, an oral glucose tolerance test (OGTT) or an oral
lipid tolerance test (OLTT). One recent study carried
out by Krug and colleagues utilised both an OGTT and
an OLTT in healthy men to investigate the dynamics of
the human metabolome in response to different chal-
lenges with a particular focus on lipids and amino acids
[18]. The study revealed that physiological challenges
increase inter-individual variation even in phenotypically
similar volunteers, which in turn revealed metabotypes
which were not observed at baseline. While Krug’s paperidentified the importance of challenging the homeostatic
state, to date the literature on postprandial response of
lipids after an OLTT is limited and more work is needed
to progress the use of these challenge tests in nutrition
research.
It is well established that exercise has a beneficial role
on the lipid profile of both healthy individuals and individ-
uals suffering from the metabolic syndrome [9, 23–25].
Early studies have shown that VO2max correlates inversely
with markers of the metabolic syndrome; including triac-
ylglycerols (TAG) [26, 27], however to date there is limited
data demonstrating the effects of aerobic fitness level on
lipidomic profiles of healthy individuals. Furthermore, lit-
tle is known on the impact of fitness level on the dynamic
response to a challenge test. Therefore the objectives of
the present work were to (1) determine the lipidomic
response to an OLTT and (2) examine the impact of
aerobic fitness on the plasma lipidomic profile.Results
Detailed lipidomic analysis was performed on a total of
40 subjects over the timecourse of an OLTT. The sub-
jects had an average age of 35 ± 14 (years) and average
BMI of 26.5 ± 6.3 (kg/m2) (Table 1). The fitness level as
determined by VO2max ranged from 8 ml/min/kg to
65 ml/min/kg. The low fitness group were defined as
subjects with a VO2max < 42 ml/min/kg and the high
fitness group were defined as subjects with a VO2max >
43 ml/min/kg.Dynamic changes in the lipid profiles following an OLTT
Mixed model repeated measures analysis identified lipids
which were significantly changing over time during the
OLTT (Table 2). The results revealed that the greatest
numbers of lipids were changing at timepoints 120 and
180 min. Sixty one lipids were significantly different
between the baseline value at the 120 min timepoint.
For the 180 min timepoint there were seventy six lipids
significantly different from baseline measurements.
Examples of the alterations during the timecourse are
given in Additional file 1: Figure S1. It should also be
noted that the TAG response was not significantly different
between males and females (Additional file 1: Figure S2).
Table 2 Lipids which change significantly during an OLTT
60 min 120 min 180 min 240 min 300 min
LPE.a.C16.0 LPC.a.C16.0 LPC.a.C16.0 LPC.a.C18.1 LPC.a.C18.0
LPE.a.C20.4 LPC.a.C18.2 LPC.a.C18.0 LPC.a.C18.2 LPC.a.C18.1
N.C11.0.Cer.2H. LPC.a.C20.4 LPC.a.C18.1 LPC.a.C20.4 LPC.a.C18.2
N.C12.1.Cer.2H. LPE.a.C16.0 LPC.a.C18.2 LPE.a.C18.1 LPC.a.C20.4
N.C17.1.Cer LPE.a.C18.0 LPC.a.C20.4 LPE.a.C18.2 LPC.e.C18.0
N.C19.0.OH.Cer LPE.a.C18.1 LPC.e.C18.0 LPE.a.C20.4 LPE.a.C18.1
N.C20.0.OH.Cer LPE.a.C18.2 LPE.a.C16.0 LPE.a.C22.6 LPE.a.C18.2
N.C21.0.OH.Cer LPE.a.C20.4 LPE.a.C18.0 N.C12.1.Cer.2H. LPE.a.C20.4
N.C25.0.Cer.2H. LPE.a.C22.6 LPE.a.C18.1 N.C14.0.OH.Cer LPE.a.C22.6
PC.aa.C32.1 N.C13.0.Cer LPE.a.C18.2 N.C16.1.Cer N.C13.0.Cer
PC.aa.C32.2 N.C16.1.Cer LPE.a.C20.4 N.C21.0.OH.Cer N.C13.1.Cer
PC.aa.C36.5 N.C20.0.Cer.2H. LPE.a.C22.6 N.C23.0.Cer N.C15.0.OH.Cer
PC.aa.C38.3 N.C20.0.OH.Cer N.C13.0.Cer N.C27.0.Cer.2H. N.C16.1.Cer
PC.aa.C38.4 N.C20.0.OH.Cer.2H. N.C16.1.Cer PC.aa.C34.2 N.C21.0.Cer
PC.aa.C38.5 N.C21.0.Cer N.C21.0.OH.Cer PC.aa.C36.0 N.C21.0.OH.Cer
PC.aa.C38.6 N.C21.0.OH.Cer N.C22.0.Cer PC.aa.C36.2 N.C23.0.Cer
PC.aa.C40.4 N.C23.0.Cer N.C23.0.Cer PC.aa.C36.3 N.C25.0.OH.Cer
PC.aa.C40.5 N.C24.0.OH.Cer.2H. N.C24.0.Cer PC.aa.C36.4 N.C27.0.Cer.2H.
PC.aa.C40.6 N.C25.0.Cer N.C25.0.Cer PC.aa.C36.5 N.C27.0.OH.Cer
PC.aa.C40.7 N.C27.0.Cer N.C25.0.Cer.2H. PC.aa.C38.5 PC.aa.C34.2
PC.ae.C32.1 N.C27.0.Cer.2H. N.C27.0.Cer.2H. PC.aa.C38.6 PC.aa.C36.2
PC.ae.C34.3 N.C8.0.OH.Cer PC.aa.C34.1 PC.ae.C36.2 PC.aa.C36.3
PC.ae.C36.3 PC.aa.C32.1 PC.aa.C34.2 PC.ae.C36.4 PC.aa.C36.4
PC.ae.C36.4 PC.aa.C34.1 PC.aa.C34.3 PC.ae.C38.4 PC.aa.C36.5
PC.ae.C38.2 PC.aa.C34.2 PC.aa.C36.0 PC.ae.C38.5 PC.aa.C38.3
PC.ae.C38.3 PC.aa.C34.3 PC.aa.C36.1 PC.ae.C38.6 PC.aa.C38.4
PC.ae.C38.4 PC.aa.C36.0 PC.aa.C36.2 PE.aa.C22.2 PC.aa.C38.5
PC.ae.C38.5 PC.aa.C36.1 PC.aa.C36.3 PE.aa.C36.2 PC.aa.C38.6
PC.ae.C38.6 PC.aa.C36.2 PC.aa.C36.4 PG.aa.C34.0 PC.aa.C40.6
PC.ae.C40.5 PC.aa.C36.3 PC.aa.C36.5 PG.aa.C36.0 PC.aa.C40.7
PE.aa.C22.2 PC.aa.C36.4 PC.aa.C38.3 PG.aa.C36.2 PC.ae.C34.6
PG.aa.C36.3 PC.aa.C36.5 PC.aa.C38.4 PS.aa.C36.4 PC.ae.C38.1
PS.aa.C36.4 PC.aa.C38.3 PC.aa.C38.5 PS.aa.C40.5 PC.ae.C38.2
PS.aa.C40.5 PC.aa.C38.4 PC.aa.C38.6 PC.ae.C38.3
SM.C18.1 PC.aa.C38.5 PC.aa.C40.4 PC.ae.C38.4
SM.C20.1 PC.aa.C38.6 PC.aa.C40.5 PC.ae.C38.5
SM.C20.2 PC.aa.C40.4 PC.aa.C40.6 PC.ae.C38.6
SM.C21.0 PC.aa.C40.5 PC.aa.C40.7 PE.aa.C22.2
SM.C21.1 PC.aa.C40.6 PC.ae.C32.0 PE.aa.C36.2
SM.C22.0 PC.aa.C40.7 PC.ae.C32.1 PE.aa.C36.3
SM.C22.1 PC.ae.C32.1 PC.ae.C34.1 PG.aa.C34.0
SM.C23.0 PC.ae.C36.4 PC.ae.C34.2 PG.aa.C36.1
SM.C23.1 PC.ae.C36.5 PC.ae.C36.2 PG.aa.C36.2
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Mixed model regression analysis was performed using the lme4 package in the R programming language for statistical computing, R version 2.15.0 and lme4
version 0.999999-0. Each post prandial time point was compared to base line value p < 0.05 was considered significantly different
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change > 1.5 compared to fasting values. Five lipids
namely LPE a C18:2, LPE a C18:1, PE aa C36:2, PE aa
C36:3 and N-C16:1-Cer, all had a fold change of > 1.5 at
120 min and this fold change remained for the timecourse
of the OLTT. N-C10:0(OH)-Cer(2H) and N-C26:0-
Cer(2H) had a fold change >1.5 at 60 min, PE aa C36:1,
PG aa C34:1 and N-C24:0(OH)-Cer(2H) had a fold change
of >1.5 at 180 min and N-C25:0(OH)-Cer fold change >1.5at 300 min. Finally PG aa C36:2 had a fold change of >1.5
at 120 and 180 min. Visualisation of the changes was
achieved using heat maps (Fig. 1). The heat maps from the
PEs and the PCs concur that the greatest fold change
differences were at 120 and 180 min. Interestingly the
saturated LPCs had increased fold differences at 60 min
while the unsaturated LPC had decreased fold changes
compared to baseline at 60 min. These fold changes where
inverted at 300 min with the saturated LPCs having a
T60 T120 T180 T240 T300 T60 T120 T180 T240 T300 T60 T120 T180 T240 T300
Fig. 1 Heat maps showing the fold change of PCs, PEs and LPCs which change significantly from baseline value at each time point during the
OLTT. Heat map visualisation of PCs, PEs and LPCs which change significantly from baseline value at each time point during the OLTT. Fold changes
from baseline were calculated and are represented in the heat map; Red represents a positive fold change, green represents a negative fold change
Table 3 Biochemical, metabolic and inflammatory parameters
for the low and high fitness groups
Low fitness High fitness P Value
Gender M/F 11/11 9/9 ns
Age (Years) 39 ± 14 29 ± 11 0.017
Weight (Kg) 87.96 ± 22.69 71.96 ± 10.54 0.009
BMI (kg/m2) 28.95 ± 7.23 23.54 ± 3.16 0.005
Percentage body fat (%) 34.31 ± 14.12 19.96 ± 8.05 0.001
VO2MAX (ml/min/kg) 28.5 ± 7.4 54.4 ± 7.0 <0.001
C Peptide (ng/ml) 4.58 ± 3.3 2.31 ± 1.90 0.114
Insulin (μIU/ml) 14.74 ± 9.36 7.86 ± 5.23 0.072
Glucose (mmol/l) 5.62 ± 1.04 5.54 ± 0.46 0.837
Cholesterol (mmol/l) 4.97 ± 0.99 4.61 ± 1.09 0.285
HDL Cholesterol (mmol/l) 1.40 ± 0.43 1.42 ± 0.37 0.893
Triglycerides (mmol/l) 1.31 ± 0.60 1.01 ± 0.36 0.067
HOMA-IR 3.94 ± 2.51 1.80 ± 1.33 0.040
TNFα (pg/ml) 5.55 ± 3.31 6.11 ± 5.36 0.693
IL6 (pg/ml) 2.29 ± 2.55 1.10 ± 0.40 0.094
Data are means ± SD. P values are based on ANOVA between fitness groups
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LPCs had a positive fold changes at the final time point
measured.
Linear regression analysis of the baseline values of
five lipids with a fold change greater than 1.5 at
120 min and for the remainder of the OLTT revealed
that three of the lipids, LPE a C18:2, PE aa C36:2 andTable 4 List of baseline differences in lipids between low and
high fitness groups
Low fitness High fitness P Value
PE ae C34:3 0.136 ± 0.039 0.169 ± 0.041 0.017
PE ae C36:3 0.381 ± 0.144 0.485 ± 0.138 0.046
PC ae C34:2 6.027 ± 2.344 8.783 ± 3.605 0.008
PC ae C34:3 4.035 ± 1.836 6.949 ± 3.156 0.004
PC ae C36:3 3.988 ± 2.108 6.159 ± 2.163 0.027
PC ae C36:4 11.600 ± 2.350 14.015 ± 3.279 0.043
PC ae C36:5 9.067 ± 2.886 11.535 ± 3.542 0.044
PC ae C38:2 0.727 ± 0.416 1.305 ± 0.509 0.025
N-C10:0-Cer 0.031 ± 0.012 0.042 ± 0.016 0.035
Data are means ± SD (μM). P values are based on multivariate GLM of between
group comparisons adjusted for age and BMI and corrected for
multiple comparisons
PE phosphoethanolamines, PC phosphatidylcholine, Cer ceramide
Table 5 Lipids displaying a differential response according to fitness level during an OLTT
60 min 120 min 180 min 240 min 300 min
N.C10.1.Cer N.C11.0.Cer LPC.a.C16.0 LPC.a.C16.0 LPC.a.C16.0
N.C19.1.Cer N.C11.0.OH.Cer.2H LPC.a.C18.0 LPC.a.C18.1 LPC.a.C18.0
N.C21.0.OH.Cer N.C12.0.OH.Cer LPC.a.C18.1 LPC.a.C20.4 LPC.a.C18.1
PC.aa.C32.2 N.C14.0.Cer LPC.a.C20.4 LPE.a.C20.4 LPC.a.C18.2
PG.aa.C36.3 N.C15.0.OH.Cer LPC.e.C18.0 LPE.a.C22.6 LPC.a.C20.4
SM.C21.1 N.C21.0.OH.Cer LPE.a.C16.0 N.C10.0.Cer LPC.e.C18.0
N.C21.1.Cer LPE.a.C18.0 N.C14.0.Cer LPE.a.C18.0
N.C25.0.Cer.2H LPE.a.C20.4 N.C14.0.OH.Cer LPE.a.C20.4
N.C27.0.OH.Cer.2H LPE.a.C22.6 N.C14.1.Cer LPE.a.C22.6
N.C8.0.OH.Cer N.C10.0.Cer N.C17.1.Cer.2H N.C10.0.Cer
PC.ae.C34.6 N.C12.0.Cer N.C19.1.Cer N.C12.0.Cer
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Variables were analysed using mixed model analysis. Timepoint differences p < 0.05 were considered significantly different
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both at fasting and at peak during the OLTT
(Additional file 1: Tables S1 and S2).
Impact of fitness level on the lipidomic profile
Biochemical, metabolic and inflammatory parameters for
both groups are shown in Table 3. Age, BMI, weight,
percentage body fat, fitness level and HOMA-IR were
significantly different between the low and high fitness
group. There were no significant differences observed in
glucose concentration, insulin, or cholesterol. Analysis of
the impact of fitness level on the fasting lipidomic
profile revealed 9 lipids that were significantly lower in
the low fitness compared to the high fitness group
(Table 4). However, analysis of the response to the
OLTT revealed significant interactions between time and
fitness group for a greater number of lipids (Table 5).
Interestingly, the timecourse analysis revealed that time
points 180 and 300 min had the greatest number of
group x time interactions. The lipid classes which had
significant group x time interaction at180 and 300 min
were; PCs, SM and ceramides. Further analyses revealed
that the changes in response to the lipid challenge were
more pronounced in the high fitness group.
Discussion
The present study revealed a significant impact of exercise
on the lipidomic profile and described the postprandial
lipidomic profile. Moreover, detailed analysis of the
dynamic response to the lipid challenge supports the
hypothesis that examination of metabolites/proteins in the
postprandial state reveals more information compared to
analysis in the fasting state [28].
Throughout the day, people are primarily in a post-
prandial state; thus fasting lipid values may not always
reflect the relative risk of cardiovascular related diseases.
There is therefore a need to move to analysis of lipids
following challenge tests such as the OLTT. The present
study adds to our knowledge of the modulation of lipidprofiles following dietary challenges. Fold change
analysis revealed that the largest changes compared to
baseline during an OLTT were seen in PEs, LPEs, PGs,
and ceramides. In particular LPE a C18:2, LPE a C18:1,
PE aa C36:2, PE aa C36:3 and N-C16:1-Cer, all had a
fold change of > 1.5 at 120 min and this fold change
remained >1.5 for the remainder of the OLTT. The PE
family of lipids represent about 25 % of mammalian
phospholipids and in recent years their importance in a
number of cellular processes has emerged: PE is now
recognised as being important for mitochondrial func-
tion, mitochondrial morphology and autophagy [29–31].
The importance of the significant increase in these lipids
during an OLTT remains to be resolved. Further analysis
of the 5 lipids with a fold change > 1.5 revealed that
baseline values of LPE a C18:2, PE aa C36:2, PE aa
C36:3 were predictive of fasting and peak TAG concen-
tration. There is a large body of evidence that
demonstrates that postprandial hypertriglyceridemia is
an independent risk for cardio vascular disease [32–34].
Relationship of the specific LPE and PEs with the TAG
concentrations is interesting in light of the fact that
plasma concentrations of LPE a C18:2 were found to be
elevated in subjects with diabetes [35]. Further investiga-
tion into the role of LPE and PE in cardiovascular
diseases is warranted.
The present analysis revealed that the dynamic
changes in LPCs depended on the saturation level of the
LPC. Unsaturated LPCs had decreased fold changes
compared to baseline at 60 min while saturated LPCs
had increased fold changes compared to baseline at
60 min. These fold changes were inverted at 300 min
with the saturated LPCs having a negative fold change at
300 min while the unsaturated LPCs had a positive fold
changes at the final time point measured. The dynamic
changes in the LPCs are noteworthy considering the re-
ports that LPC levels are reduced in individuals with
impaired glucose tolerance [36] and that LPC C16:0 is
reduced in insulin resistant subjects with non-alcoholic
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animal study significant and rapid changes in LPC levels
were observed leading the authors to suggest that diet
and adiposity may be drivers of the LPC levels [38].
Interestingly the timecourse analysis in the animal study
revealed a differential pattern of change for the saturated
LPCs agreeing with the results found in humans in the
present study. Furthermore, a recent study has demon-
strated that lysophosphatidic acid exerts a deleterious ef-
fect on glucose disposal in high fat diet induced obesity
[39]. Further work is needed to clarify the importance of
diet for the fasting levels of LPCs.
Analysis of the effect of fitness level on the fasting lipi-
domic profile revealed that long chain phosphatidylcho-
lines (PCs) were significantly different between the low
and high fitness groups. Six phosphatidylcholines were
significantly lower in the lower fitness group. This is in
agreement with a recent study [40] in which Bye and
colleagues’ concluded low VO2max subjects had
decreased serum concentrations of phosphatidylcholines
compared to those with high VO2max. In this work, Bye
suggested that due to the lower concentrations of
phosphatidylcholines, healthy individuals with a low aer-
obic fitness may have a high Phospholipase D activity,
which may link low aerobic fitness to the future develop-
ment of CVD. Our study revealed that exploration of dy-
namic changes following a high fat challenge revealed
more significant differences according to fitness level
compared to analysis at baseline or fasting state. This
concept has emerged in the literature and has been dem-
onstrated in the context of dietary interventions [28].
Analysis of the dynamic changes revealed the greatest
changes in LPEs, PEs and Ceramides according to fitness
level. Previous research has shown that exercise has a
beneficial role on lipid profile after a dietary challenge
[41–45], whilst detraining in athletes rapidly increases
postprandial TAG response to the level of untrained
subjects [41, 42]. The present data revealed that the
change in the lipids following the lipid challenge was
more pronounced for the higher fitness group. This con-
curs with recently published data where an intervention
which modified dietary fat revealed that the extent to
which dietary fatty acids penetrate cellular lipids
depended on fitness level [46]. The authors suggest that
the strong interaction between diet and fitness level may
be due to adaptations in muscle lipid metabolism [46].
The differential response to the dietary challenge accord-
ing to fitness level is particularly important considering
the controversy surrounding the role of lipid species in
the development of muscle insulin resistance: some
studies report that increased concentrations of diacyl-
glycerols are associated with insulin resistance while
others have demonstrated that concentrations are higher
in trained athletes [47, 48]. The present work supports ahypothesis that the alterations in lipids in response to
dietary challenges may be more important than fasting
concentrations and the ability of high fitness subjects to
change lipid pools in the postprandial state may confer
beneficial effects.Conclusion
In conclusion this study has identified the key lipids
which change over the course of an OLTT and identified
a pattern of LPE and PE lipids that are significantly re-
lated to the TAG response. Significant changes due to
fitness level were observed and our data supports the
view that examination of profiles in the challenge state
reveals more information compared to analysis in the
homeostatic state.Methods
This study is part of the Metabolic Challenge Study
(MECHE) as previously described [49]. Ethical approval
was obtained from the Research Ethics Committees in
University College Dublin (UCD) (LS-08-43-Gibney-Ryan).
Two hundred and fourteen subjects aged 18–60 years
were recruited following a screening which included
evaluation of the following parameters: fasting glucose,
TAG, haemoglobin, and HDL- and LDL- cholesterol
concentrations. Individuals with a BMI <18.5 kg/m2, low
hemoglobin (<12 g/dL), elevated fasting glucose (FPG
≥7 mmol/l), cholesterol (>7.5 mmol/l), TAG (>3.8 mmol/l)
or exhibiting raised liver or kidney enzymes, any of which
warranted pharmaceutical treatment, were excluded as
previously reported [49]. Subjects were informed about
the experimental procedures and purpose of the study
prior to giving written consent. Subjects were randomised
to one of three groups; 75 subjects were randomised to
receive an OGTT and an OLTT on two separate clinical
visits. 69 subjects were randomised to two OGTTs on two
separate clinical visits. Finally 70 subjects were rando-
mised two OLTTs on two separate clinical visits. For the
present study a sub-cohort of 40 subjects (20 male, 20
female) were the upper and lower quartiles of the
estimated VO2max levels for subjects who underwent at
least 1 OLTT.
Following a 12 h overnight fast, second void urine and
blood samples were collected. The urine was immedi-
ately centrifuged at 1800 g for 10 min at 4 °C, and 1 ml
aliquots were stored at −80 °C. All individuals under-
went a 75 g OGTT according to the recommendations
of the World Health Organization (WHO)/International
Diabetes Federation IDF. Venous blood samples were
obtained directly before (=0 min) and at 10, 20, 30, 60,
90, and 120 min during the OGTT. The OLTT consisted
of 100 mL Calogen (Nutricia, Ireland) combined with
50 mL Liquid Duocal (SHS Nutrition, Netherlands) for a
Morris et al. Lipids in Health and Disease  (2015) 14:65 Page 9 of 11total of 150 mL with a fat content of 54 g fat (7 g SFA,
31 g MUFA, 16 g PUFA) and 11 g carbohydrate [49].
Venous blood samples were obtained directly before
(=0 min) and at 60, 120, 180, 240, and 300 min during
the OLTT.
Serum and plasma samples were collected using serum
tubes containing a clot activator coating, EDTA-coated
evacuated tubes and tubes containing lithium heparin.
The serum samples were allowed to clot for 30 min at
room temperature. EDTA and lithium heparin tubes
were placed directly on ice. All blood samples were cen-
trifuged at 1800 g for 15 min at 4 °C and 500 μl aliquots
were stored at −80 °C until subsequent analysis.
Body composition and fitness tests
Body composition and cardiovascular fitness assessment
were performed as described previously [50]. Height was
measured using a wall-mounted stadiometer. Weight
was measured on a calibrated beam balance platform
scale. Percentage body fat was measured via an air-dis-
placement plethysmograph, which has been shown to be
an accurate method for assessing body composition in
adults [51]. The system used in this study was the BOD
POD body composition system (Model 200OA; Life
Measurements Instruments, Concord, CA, USA).
Percentage body fat measurements were measured in
the fasting state. The VO2max test was carried out after
the volunteer received a breakfast consisting of 1 ×
250 ml orange Fruice drink, 1 × strawberry Kellogg’s®
Nutri grain® Cereal bar, 1 × medium banana and 1 ×
125 g Dale Farm Spelga low fat bio yoghurt [50]. To in-
dividualise the increment of exercise intensity during the
VO2max test, the workload of each step was calculated
from the theoretical VO2max using the Jones equation
[52]. Consequently subjects underwent a test with the
same relative incremental workload. The test consisted
of a three minute warm up at baseline followed by four
minute steady state workloads at 15, 35, 55, and 75 %.
Recovery to baseline (VO2 and heart rate returned to
baseline value and an R value under 1 was achieved) was
recorded after each increment. The subjects performed
the test on an electronically braked cycle ergometer
(Ergoline Bosh 500). Heart rate was monitored continu-
ously throughout the test and metabolic and ventilatory
responses were assessed using a computer based breath
to breath exercise analysing system (Quark b2, Cosmed,
Rome, Italy).
Lipidomic analysis
Lipidomics analysis was carried out by BIOCRATES Life
Sciences AG (Biocrates Life sciences AG, Innsbruck,
Austria) on lithium heparin plasma samples. The biologic-
ally most abundant members of (lyso-) glycerophospholi-
pids, i.e. (lyso-) glycerolphosphocholines, −ethanolamines,−serines, −glycerols, as well as sphingolipids, i.e. sphingo-
myelins, ceramides, dihydroceramides, and 2-hydroxyacyl
ceramides, were quantitatively analysed by a high through-
put flow injection ESI-MS/MS method as previously
described [15, 53]. The quantitative data analysis was per-
formed with Biocrates in-house software MetIDQ™ enab-
ling isotopic correction and basic statistical analysis. To
deal with data at or below the limit of detection only lipids
which had ≥ 70 % of subjects above the limit of detection
were included in this analysis [54]. Therefore from the
325 lipids that were measured, 240 lipids were included
for data analysis. The median intra-day CV was < 8 %
taking into account all measured lipids. The median inter-
day CV was 16 % taking into account all lipids.Biochemical and immune parameters
Clinical chemistry analysis was performed using an
RxDaytona™ chemical analyser autoanalyser (Randox La-
boratories, Crumlin, UK) and Randox reagents as previ-
ously described [49]. Details of the analytes and methods
are as follows: total cholesterol (cholesterol oxidase),
HDL-cholesterol (direct clearance), glucose (glucose oxi-
dase), triacylglycerol (lipase/glycerol kinase colorimetric),
C reactive protein (immunoturbidimetric) and NEFA
(lipase/glycerol kinase colorimetric).
The Evidence Investigator™ (Randox Laboratories,
Crumlin, Northern Ireland) metabolic array I kit was
used for the simultaneous measurement of C-peptide,
Insulin, Resistin, and Tumor Necrosis Factor-a (TNFa).
Standard quality control procedures were followed on
both analysers to ensure the integrity of the data.
HOMA-IR score was calculated using the formula;
(Fasting insulin μU/mL x fasting glucose mmol/L)/ 22.5
and Quicki score was calculated using the formula; 1 /
(log (fasting insulin μU/mL) + log(fasting glucose mg/dL).Statistical analysis
Descriptive statistics, ANOVA and general linear model
analyses were performed using PASW version 18.0 for
windows. P values were corrected for multiple compari-
sons using a Bonferroni correction where appropriate.
Data are presented as mean ± standard deviation (SD).
Mixed model regression analysis was done using the
lme4 package in the R programming language for statis-
tical computing, R version 2.15.0 and lme4 version
0.999999-0, both available under the GNU public license
(http://www.cran.r-project.org.) Lme4 is an R package
for fitting and analysing linear, non linear and general-
ised linear mixed models. Individual lipid concentrations
were visualised using the beanplots, implemented in
‘beanplot’ R package. Heatmaps were produced in R for
visualisation of fold changes in lipid concentrations.
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